260 likes | 371 Views
Reporting of Skin cancer using RCPath Standards. A regional perspective. Paul Barrett. Aim. Determine if RCPath standards have been adopted Part of network clinical guidelines (Jul13) RCPath Oct12 (revised May14) Pathology can be critical in determining cases to be discussed at MDT
E N D
Reporting of Skin cancer using RCPath Standards. A regional perspective. Paul Barrett
Aim • Determine if RCPath standards have been adopted • Part of network clinical guidelines (Jul13) • RCPath Oct12 (revised May14) • Pathology can be critical in determining cases to be discussed at MDT • Excisional intent • High risk • Incompletely excised
Planned high quality cancer care to just over 3 million people in the North of England • 8 Foundation and 1 NHSTrusts • 14 Primary Care Trusts (PCTs) • 5 localities
Method • 25 reports requested from 2014 • Each cancer type • Each centre reporting in North East • Core items in RCPath guidelines assessed • One centre failed to submit by deadline • Not all cases suitable • Not all sites had 25 cases
Melanoma • Fairly established dataset • No major changes
Results - Melanoma • 101 cases • Local MDT • 31 • Proforma • 75 • Non-proforma • 4 central (6%) • 22 local (71%)
Results - Melanoma • All cases • Macroscopic description skin ellipse • Macroscopic description lesion • Excision margins
Results - Melanoma Critical results • Breslow 1 (1/0) • Clark’s 6 (5/1) • Ulceration 7 (7/0) • 12 cases do not include vital data • All destined for review
Results - Melanoma • LVI 5 (5/0) • PNI 11 (11/0) • Microsat 52 (22/30) • Subtype 13 (12/1) • Growth phase 9 (9/0) • Stage 21 (18/3)
Results - Melanoma • Mitotic rate 2 (2/0) • Regression 17 (15/2) • TiL 14 (14/0) • All data items provided 47 (46%)
SCC • Significant change around risk status • Complexity with pT2 • Any two of • Poor differentiation • Into subcutaneous tissue • >2mm • Into reticular dermis
Results - SCC • 126 cases • Local MDT • 52 (41%) • Proforma • 63 (all central) • Non-proforma • 11 central (17%) • 52 local (82%)
Results - SCC • All cases • Macroscopic description skin ellipse • Macroscopic description lesion • Excision margins
Results - SCC Critical results • Grade 8 (8/0) • Thickness 10 (10/0) • Level 32 (30/2)
Results - SCC • LVI 7 (7/0) • PNI 22 (22/0) • Subtype 47 (47/0) • Risk 86 (54/32) • Stage 65 (41/24)
Results - SCC • Correct assessment of risk • Recorded in 40 • 3 incorrect • 2 insufficient data in report to assess • All data items provided 25% • 32 cases (2/30)
BCC • Established data set • Is it really cancer? • Multiple specimens common
Results - BCC • 159 cases • Local MDT • 86 (54%) • Proforma • 65 (all central) • Non-proforma • 8 central (17%) • 86 local (100%)
Results - BCC • All cases • Macroscopic description skin ellipse • Macroscopic description lesion
Results - BCC Key results • Growth pattern 1 (1/0) • Level 57 (56/1) • Margins 2 (1/1)
Results - BCC • LVI 28 (27/1) • PNI 15 (14/1) • Risk 85 (85/0) • Stage 92 (68/24) • All data items provided 26% • 41 cases • Combination risk and/or stage absent
Recommendations • Data could be derived • Melanoma review centrally • Confirms value in reporting by proforma • College KPI • Ensure proforma contains all core items • Re-audit or audit locally